This test is most useful if any of these apply to you.
The same tick that carries Lyme disease also carries a parasite called Babesia microti, a microscopic organism that invades and destroys your red blood cells. Unlike Lyme, babesiosis can be completely silent in healthy people or life-threatening in others, and a standard Lyme test will not detect it. If you live in or travel to the northeastern or upper midwestern United States, you may have been exposed without knowing it.
This panel measures two types of antibodies your immune system makes against Babesia microti. Together, they answer a question that no single test can answer alone: has your body encountered this parasite, and if so, was it recent or in the past? That distinction shapes everything from treatment urgency to follow-up testing.
Your immune system produces different antibody types at different stages of an infection. The first responder is IgM (immunoglobulin M), an antibody class that appears within the first one to two weeks of a new Babesia infection. IgM rises quickly and typically fades within a few months. The second antibody, IgG (immunoglobulin G), appears a bit later but persists much longer, sometimes for months to years after the parasite has been cleared.
By measuring both IgM and IgG, this panel creates a timeline. A positive IgM with a negative IgG suggests a brand-new infection. A positive IgG with a negative IgM points to a past exposure. When both are positive, you may be in the middle of an active or recently acquired infection. Neither test alone gives you this kind of staging information.
Babesia microti is transmitted by the blacklegged tick (Ixodes scapularis), the same tick responsible for Lyme disease and anaplasmosis. Because these infections share a vector, co-infection is common. A study of patients in endemic areas found that roughly 10% to 20% of people with Lyme disease also carry Babesia microti. If only Lyme is tested for, the babesiosis goes undetected.
Many healthy adults who contract babesiosis never develop obvious symptoms. A study published in the New England Journal of Medicine documented that parasites can persist in the bloodstream for up to 27 months in people who felt fine. Asymptomatic carriers pose a real risk to the blood supply. A large U.S. blood donor screening study found antibody-positive donors in every endemic state tested, contributing to FDA guidance recommending screening of donated blood for Babesia.
When symptoms do appear, they mimic many other illnesses: fever, fatigue, chills, sweating, muscle aches. Because the parasite destroys red blood cells, some people develop hemolytic anemia (a drop in red blood cells caused by their destruction). In older adults, people without a functioning spleen, and those with weakened immune systems, babesiosis can become severe or fatal.
The standard method for these antibodies is an indirect fluorescent antibody (IFA) test. Results are typically reported as a titer, a measure of how much the blood sample can be diluted before the antibody is no longer detected. For IgG, a titer of 1:64 or higher is generally reported as positive by clinical laboratories. The CDC uses a higher threshold of 1:256 or greater for its surveillance case definition of confirmed babesiosis.
| IgM Result | IgG Result | Most Likely Interpretation |
|---|---|---|
| Positive | Negative | Early or very recent infection (first 1 to 2 weeks) |
| Positive | Positive | Active or recent infection, immune response is building |
| Negative | Positive | Past infection or late-stage exposure; parasite may or may not still be present |
| Negative | Negative | No evidence of current or past Babesia microti infection |
A single positive IgG result does not confirm active infection. IgG antibodies can remain elevated for a year or longer after the parasite has been cleared. If active infection is suspected, a blood smear examined under a microscope or a PCR test (which detects the parasite's DNA directly) should be ordered alongside antibody testing to confirm parasites are still circulating.
Antibody tests have a timing problem. In the first few days of infection, neither IgM nor IgG may have risen high enough to be detected. If you were bitten very recently and your results are negative, but symptoms persist, retesting in two to four weeks can catch a delayed antibody response.
Cross-reactivity is another consideration. Other Babesia species (such as Babesia duncani, found on the West Coast) and related parasites like Plasmodium (the cause of malaria) can occasionally trigger a weak positive result on a Babesia microti antibody test. If you have traveled to malaria-endemic regions, mention this when interpreting results.
People with weakened immune systems may produce lower antibody levels or fail to develop detectable antibodies altogether. In immunocompromised individuals, direct detection methods like PCR or blood smear are more reliable than antibody testing alone.
For anyone with a confirmed or suspected Babesia infection, serial antibody testing adds real value. A rising IgG level over two to four weeks supports a diagnosis of active infection. A falling level after treatment suggests the infection is resolving. Persistent high antibody levels, especially when paired with ongoing symptoms, may indicate treatment failure or reinfection.
If you live in an endemic area and spend time outdoors, a baseline antibody level is worth having. A future positive result means much more when you can compare it to a known negative. For those who have been treated for babesiosis, follow-up testing at three and six months helps confirm the parasite has been cleared, especially because persistent or relapsing infection (parasites continuing to circulate in the blood) has been documented in immunocompromised individuals.
If both antibodies are negative and you have no symptoms, no further action is needed. If either antibody is positive or you have symptoms consistent with babesiosis (fever, fatigue, dark urine, anemia after a tick bite), bring your results to an infectious disease physician. They will likely order confirmatory testing: a blood smear to look for the parasite inside red blood cells and a PCR test to detect its DNA.
Because the same tick transmits multiple infections, a positive Babesia result should prompt testing for Lyme disease and anaplasmosis if those have not already been checked. Co-infections can complicate treatment and slow recovery. A complete blood count (CBC) and markers of red blood cell destruction, such as lactate dehydrogenase (LDH, an enzyme released from damaged cells) and haptoglobin (a protein that drops when red blood cells break apart), help assess whether the parasite is actively destroying your red blood cells.
Babesiosis is treatable with antibiotics, and early identification through antibody testing helps ensure prompt care. People without a functioning spleen or with weakened immune systems may need longer treatment and closer follow-up, as relapse rates are higher in these groups.
Babesia Microti Antibodies is best interpreted alongside these tests.